Literature DB >> 24615144

[Long-term use of an endovascular temperature catheter].

D Krizanac1, A Bojic, W Rabitsch, P Schellongowski, G J Locker, K Laczika, T Staudinger.   

Abstract

A patient suffering from severe cutaneous graft versus host disease (GvHD) developed generalized epidermolysis and refractory hypothermia. Due to the insufficient effect of traditional rewarming methods, an endovascular temperature catheter was placed via the femoral vein to achieve and maintain normothermia over a period of 31 days. This case shows that an endovascular temperature modulation device primarily made for short-term use may be safe and effective even over weeks and may offer an alternative to other rewarming methods in patients with severe epidermolysis and burns.

Entities:  

Mesh:

Year:  2014        PMID: 24615144     DOI: 10.1007/s00063-014-0353-4

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  10 in total

1.  Successful use of venovenous extracorporeal membrane oxygenation in accidental hypothermic cardiac arrest.

Authors:  Ravindranath Tiruvoipati; Senthil K Balasubramanian; Espeed Khoshbin; Leonidas Hadjinikolaou; Andrzej W Sosnowski; Richard K Firmin
Journal:  ASAIO J       Date:  2005 Jul-Aug       Impact factor: 2.872

Review 2.  Deep vein thrombosis associated with central venous catheters - a review.

Authors:  C J Rooden; M E T Tesselaar; S Osanto; F R Rosendaal; M V Huisman
Journal:  J Thromb Haemost       Date:  2005-06-24       Impact factor: 5.824

3.  The association between hypothermia, prehospital cooling, and mortality in burn victims.

Authors:  Adam J Singer; Breena R Taira; Henry C Thode; Jane E McCormack; Mark Shapiro; Ani Aydin; Christopher Lee
Journal:  Acad Emerg Med       Date:  2010-04       Impact factor: 3.451

4.  Catheter related venous thrombosis with cooling and warming catheters: two case reports.

Authors:  Bertrand Prunet; Guillaume Lacroix; Julien Bordes; Raphael Poyet; Erwan D'Aranda; Philippe Goutorbe
Journal:  Cases J       Date:  2009-09-08

5.  Efficacy and safety of endovascular cooling after cardiac arrest: cohort study and Bayesian approach.

Authors:  Michael Holzer; Marcus Müllner; Fritz Sterz; Oliver Robak; Andreas Kliegel; Heidrun Losert; Gottfried Sodeck; Thomas Uray; Andrea Zeiner; Anton N Laggner
Journal:  Stroke       Date:  2006-06-08       Impact factor: 7.914

6.  Maintenance of normothermia during burn surgery with an intravascular temperature control system: a non-randomised controlled trial.

Authors:  Bertrand Prunet; Yves Asencio; Guillaume Lacroix; Julien Bordes; Ambroise Montcriol; Erwan D'Aranda; Jean-Philippe Pradier; Eric Dantzer; Eric Meaudre; Philippe Goutorbe; Eric Kaiser
Journal:  Injury       Date:  2010-09-16       Impact factor: 2.586

7.  Active intravascular rewarming for hypothermia associated with traumatic injury: early experience with a new technique.

Authors:  Edward E Taylor; James P Carroll; Matthew A Lovitt; Laura B Petrey; Paul E Gray; Cyndi J Mastropieri; Michael L Foreman
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-04

8.  Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm.

Authors:  Martin A Seule; Carl Muroi; Susanne Mink; Yasuhiro Yonekawa; Emanuela Keller
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

9.  Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial.

Authors:  Gregor Broessner; Ronny Beer; Peter Lackner; Raimund Helbok; Marlene Fischer; Bettina Pfausler; Janelle Rhorer; Lea Küppers-Tiedt; Dietmar Schneider; Erich Schmutzhard
Journal:  Stroke       Date:  2009-09-17       Impact factor: 7.914

10.  Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study.

Authors:  Erich Schmutzhard; Klaus Engelhardt; Ronny Beer; Gregor Brössner; Bettina Pfausler; Heinz Spiss; Iris Unterberger; Andreas Kampfl
Journal:  Crit Care Med       Date:  2002-11       Impact factor: 7.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.